These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1491735)

  • 21. The cholinergic system in Alzheimer's disease.
    Kása P; Rakonczay Z; Gulya K
    Prog Neurobiol; 1997 Aug; 52(6):511-35. PubMed ID: 9316159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor.
    Mimori Y; Nakamura S; Yukawa M
    Behav Brain Res; 1997 Feb; 83(1-2):25-30. PubMed ID: 9062656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential inhibition of acetylcholinesterase molecular forms in rat brain.
    Ogane N; Giacobini E; Messamore E
    Neurochem Res; 1992 May; 17(5):489-95. PubMed ID: 1528356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetylcholinesterase fibers and the development of senile plaques.
    Tago H; McGeer PL; McGeer EG
    Brain Res; 1987 Mar; 406(1-2):363-9. PubMed ID: 3567634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral cholinergic disturbances in Alzheimer's disease.
    Rakonczay Z; Horváth Z; Juhász A; Kálmán J
    Chem Biol Interact; 2005 Dec; 157-158():233-8. PubMed ID: 16243305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
    Darreh-Shori T; Hellström-Lindahl E; Flores-Flores C; Guan ZZ; Soreq H; Nordberg A
    J Neurochem; 2004 Mar; 88(5):1102-13. PubMed ID: 15009666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related changes in acetylcholinesterase and its molecular forms in various brain areas of rats.
    Meneguz A; Bisso GM; Michalek H
    Neurochem Res; 1992 Aug; 17(8):785-90. PubMed ID: 1641060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in the distribution of acetylcholinesterase molecular forms in frontoparietal cortex of the rat following nucleus basalis lesions with kainic acid.
    Bisso GM; Diana G; Fortuna S; Meneguz A; Michalek H
    Brain Res; 1988 May; 449(1-2):391-4. PubMed ID: 3395855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.
    Sberna G; Sáez-Valero J; Li QX; Czech C; Beyreuther K; Masters CL; McLean CA; Small DH
    J Neurochem; 1998 Aug; 71(2):723-31. PubMed ID: 9681463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.
    Sáez-Valero J; Sberna G; McLean CA; Small DH
    J Neurochem; 1999 Apr; 72(4):1600-8. PubMed ID: 10098867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
    Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of hypoxia on cholinesterase activity in rat sensorimotor cortex].
    Kochkina EG; Plesneva SA; Zhuravin IA; Turner AJ; Nalivaeva NN
    Zh Evol Biokhim Fiziol; 2015; 51(2):95-102. PubMed ID: 26027382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease.
    Small DH; Moir RD; Fuller SJ; Michaelson S; Bush AI; Li QX; Milward E; Hilbich C; Weidemann A; Beyreuther K
    Biochemistry; 1991 Nov; 30(44):10795-9. PubMed ID: 1718425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preparation and assessment of an animal model of Alzheimer's disease].
    Matsuda H; Kinuya K; Tsuji S; Terada H; Shiba K; Kojima K; Mori H; Sumiya H; Hisada K
    Kaku Igaku; 1990 Aug; 27(8):883-91. PubMed ID: 2232358
    [No Abstract]   [Full Text] [Related]  

  • 36. G4 forms of acetylcholinesterase and butyrylcholinesterase in normal and dystrophic mouse muscle differ in their interaction with Ricinus communis agglutinin.
    Cabezas-Herrera J; Moral-Naranjo MT; Campoy FJ; Vidal CJ
    Biochim Biophys Acta; 1994 Feb; 1225(3):283-8. PubMed ID: 8312375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dementia without cholinergic deficit.
    Riekkinen PJ; Soininen H; Sirviö J; Reinikainen K; Helkala EL; Paljärvi L
    Gerontology; 1987; 33(3-4):268-72. PubMed ID: 3653707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylcholinesterase provides deeper insights into Alzheimer's disease.
    Shen ZX
    Med Hypotheses; 1994 Jul; 43(1):21-30. PubMed ID: 7968717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease.
    Heckers S; Geula C; Mesulam MM
    Neurobiol Aging; 1992; 13(4):455-60. PubMed ID: 1508295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcholinesterase in Huntington's and Alzheimer's diseases: simultaneous enzyme assay and immunoassay of multiple brain regions.
    Hammond P; Brimijoin S
    J Neurochem; 1988 Apr; 50(4):1111-6. PubMed ID: 2964509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.